News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Organon (AKZOY) Takeover Too Costly and Complicated, Says Merck & Co., Inc. (MRK); Merck Plans to Close R&D and Production Line with the Loss of Over 2,000 Jobs



3/7/2011 6:53:36 AM

Dutch News -- US pharmaceuticals giant Merck turned down an offer for its Organon unit in Oss because it would cost the company $700m more than closing it down, the company told a court hearing on Friday.

Read at News Release


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES